Faecal S100A12 (f-SA12)
Showing 1 - 25 of >10,000
Calcium Binding Protein S100A12 in Diagnosis and Prognosis of
Not yet recruiting
- Diagnoses Disease
- S100A12
- (no location specified)
Jun 21, 2022
COVID-19 Trial in Sohag (real time PCR)
Recruiting
- COVID-19
- real time PCR
-
Sohag, EgyptSohag University Hospital
Jan 20, 2022
Post-COVID-19 Syndrome Trial in Kiel, Tuebingen, Würzburg (Prednisolone 20 mg/ 5 mg, Vitamin B compound (100mg B1, 50 mg B6, 500
Recruiting
- Post-COVID-19 Syndrome
- Prednisolone 20 mg/ 5 mg
- +3 more
-
Kiel, Germany
- +2 more
Dec 1, 2022
Peripheral Sensory Neuropathy of Different Etiologies Trial in Mexico City (Vitamin B combination tablet, Placebo Tablet)
Recruiting
- Peripheral Sensory Neuropathy of Different Etiologies
- Vitamin B combination tablet
- Placebo Tablet
-
Mexico City, MexicoRM Pharma Specialists S.A. de C.V.
Nov 15, 2022
Asthma Trial in Edegem (Test product (T):CHF 5993 BDP/FF/GB 200/6/12.5 µg pMDI, Reference product 1 (R1): CHF 5993 BDP/FF/GB
Recruiting
- Asthma
- Test product (T):CHF 5993 BDP/FF/GB 200/6/12.5 µg pMDI
- +2 more
-
Edegem, Antwerpen, BelgiumSGS Belgium NV - Clinical Pharmacology Unit
Jun 1, 2023
Rheumatoid Arthritis Trial in Chi?inau (AP1189, 60 mg, AP1189, 80 mg, AP1189, 100 mg)
Recruiting
- Rheumatoid Arthritis
- AP1189, 60 mg
- +3 more
-
Chișinău, Moldova, Republic ofTimofei Mosneaga Republican Clinical Hospital
Jan 5, 2023
Coronavirus Disease-2019 (COVID-19) Prevention Trial in Worldwide (Ad26.COV2.S)
Active, not recruiting
- Coronavirus Disease-2019 (COVID-19) Prevention
- Ad26.COV2.S
-
Buenos Aires, Argentina
- +17 more
Jan 17, 2023
SARS CoV 2 Infection Trial in Mexico City (Recombinant NDV Vectored Vaccine for SARS-CoV-2, Placebo)
Recruiting
- SARS CoV 2 Infection
- Recombinant NDV Vectored Vaccine for SARS-CoV-2
- Placebo
-
Mexico City, Cdmx, Mexico
- +3 more
Mar 23, 2022
Asthma Trial in Worldwide (Tezepelumab, Placebo)
Recruiting
- Asthma
- Tezepelumab
- Placebo
-
Montgomery, Alabama
- +38 more
Aug 30, 2023
Survivorship of Press Fit Condylar Sigma Fixed Bearing Knee
Completed
- Knee Osteoarthritis
- P.F.C. Sigma Knee
-
Schwandorf, Deutschland, Germany
- +4 more
Nov 29, 2021
Atopic Dermatitis Trial in India (Abrocitinib 100 mg, Abrocitinib 200 mg)
Recruiting
- Atopic Dermatitis
- Abrocitinib 100 mg
- Abrocitinib 200 mg
-
New Delhi, Delhi, India
- +14 more
Jan 9, 2023
Pulmonary Hypertension (PAH) in Patients With Thalassemia
Completed
- Thalassemia Major
- +2 more
- Physician standard-of-care according to ESC/ERS Guidelines
-
Orbassano, Turin, Italy
- +7 more
Aug 3, 2022
Respiratory Syncytial Virus Trial in Worldwide (Ad26.RSV.preF, Placebo, Nimenrix)
Completed
- Respiratory Syncytial Virus
- Ad26.RSV.preF
- +2 more
-
Geelong, Australia
- +24 more
Nov 23, 2021
Pneumococcal Disease Trial in Worldwide (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)
Active, not recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- 13-valent pneumococcal conjugate vaccine
-
Nedlands, Western Australia, Australia
- +63 more
Nov 3, 2022
Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)
Not yet recruiting
- Classic Hodgkin Lymphoma
- Biospecimen Collection
- +19 more
- (no location specified)
Jan 6, 2023
Breast Cancer, Hypercalcemia of Malignancy, Metastatic Cancer Trial in United Kingdom (zoledronic acid, quality-of-life
Terminated
- Breast Cancer
- +4 more
- zoledronic acid
- quality-of-life assessment
-
Bournemouth, England, United Kingdom
- +29 more
May 23, 2022
Respiratory Syncytial Virus, Human Metapneumovirus Trial in Worldwide (mRNA-1345, mRNA-1365, Placebo)
Recruiting
- Respiratory Syncytial Virus
- Human Metapneumovirus
- mRNA-1345
- +3 more
-
Andalusia, Alabama
- +72 more
Feb 15, 2023
Primary Open Angle Glaucoma, Ocular Hypertension Trial in India, Russian Federation (Brinzolamide ophthalmic suspension, Azopt®)
Recruiting
- Primary Open Angle Glaucoma
- Ocular Hypertension
- Brinzolamide ophthalmic suspension
- Azopt®
-
Srikakulam, Andhra Pradesh, India
- +38 more
Dec 23, 2022
Recurrence After Whipple's (RAW) Study
Active, not recruiting
- Pancreatic Cancer
- +13 more
- Pancreaticoduodenectomy
-
Clayton, Victoria, Australia
- +28 more
Jan 13, 2023
Healthy Volunteers Trial in Arzo (procedure, device, drug)
Completed
- Healthy Volunteers
- charcoal block
- +2 more
-
Arzo, Via F.A. Giorgioli, 14, SwitzerlandCROSS Research SA
Jul 30, 2020
Peripheral T-cell Lymphoma Trial in Worldwide (brentuximab vedotin, cyclophosphamide, doxorubicin)
Recruiting
- Peripheral T-cell Lymphoma
- brentuximab vedotin
- +3 more
-
Birmingham, Alabama
- +45 more
Jan 4, 2023
Metastatic Breast Cancer Trial in Worldwide (metastatic lesion biopsy)
Suspended
- Metastatic Breast Cancer
- metastatic lesion biopsy
-
Brussels, Belgium
- +59 more
Jan 17, 2023
Overactive Bladder Trial in Worldwide (Placebo, BAY1817080)
Completed
- Overactive Bladder
- Placebo
- BAY1817080
-
Botany, New South Wales, Australia
- +27 more
Feb 9, 2022
Rheumatoid Arthritis Trial in Worldwide (LY3871801, Placebo)
Not yet recruiting
- Rheumatoid Arthritis
- LY3871801
- Placebo
-
Woodland Hills, California
- +46 more
May 10, 2023